100 mcg of cjc1295 three times daily

Administering CJC-1295 involves some complexity and potential risks. Andrew Huberman explains that CJC-1295 is a growth hormone secreting peptide designed to be long-lasting, typically taken once or twice a week. Its long duration of action is due to a drug affinity complex added to the peptide, which extends its effects on growth hormone and IGF-1 levels for several days. However, he notes that CJC-1295 has been associated with significant risks, including a death in clinical trials potentially linked to cardiovascular issues and fluid retention 1.

Additionally, Peter Attia highlights that CJC-1295 falls into a regulatory gray area, lacking full FDA approval and standards, which implies it is generally not sold over the counter and likely requires a prescription 2. Therefore, it's crucial to approach its use cautiously and under medical supervision.